![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61K 39/39 | (2013.01) | ||
A61K 39/39 | (2006.01) | ||
A61K2039/5254 | (2013.01) | ||
A61K 39/0011 | (2013.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 37/04 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 39/001193 | (2018.08) | ||
A61K 39/001182 | (2018.08) | ||
A61K 39/001194 | (2018.08) | ||
A61K 39/00117 | (2018.08) | ||
A61K 39/00115 | (2018.08) | ||
A61K 39/001106 | (2018.08) |
(11) | Number of the document | 3142690 |
(13) | Kind of document | T |
(96) | European patent application number | 15733563.9 |
Date of filing the European patent application | 2015-05-08 | |
(97) | Date of publication of the European application | 2017-03-22 |
(45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/029855 |
Date | 2015-05-08 |
(87) | Number | WO 2015/175334 |
Date | 2015-11-19 |
(30) | Number | Date | Country code |
201461992788 P | 2014-05-13 | US |
(72) |
FOY, Susan , US
MANDL, Stefanie , US
ROUNTREE, Ryan , US
FRANZUSOFF, Alex , US
|
(73) |
Bavarian Nordic A/S ,
Hejreskovvej 10A, 3490 Kvistgaard,
DK
|
(54) | COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST |
COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST |